364 results on '"DeNicola, Gina"'
Search Results
102. Decision letter: Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser
103. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
104. Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
105. Abstract C46: Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms
106. Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
107. PHGDH supports liver ceramide synthesis and sustains lipid homeostasis
108. Correction: Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
109. A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?
110. NNT Regulates Mitochondrial Metabolism in NSCLC Through Maintenance of Fe-S Protein Function
111. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer
112. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
113. The Non-Essential Amino Acid Cysteine Becomes Essential for Tumor Proliferation and Survival
114. Author response: Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
115. The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism
116. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
117. Metabolism and epigenetics: Drivers of tumor cell plasticity and treatment outcomes
118. Stressing Out PanIN: NRF2 Pushes over the Edge
119. Abstract B04: NRF2 regulates serine biosynthesis in pancreatic ductal adenocarcinoma
120. NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
121. Erratum: NRF2 regulates serine biosynthesis in non–small cell lung cancer
122. Cancer’s Fuel Choice: New Flavors for a Picky Eater
123. NRF2 regulates serine biosynthesis in non–small cell lung cancer
124. The utility of transposon mutagenesis for cancer studies in the era of genome editing
125. Long-sought mediator of vitamin K recycling discovered.
126. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
127. RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
128. Abstract NG05: Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53 null tumors
129. Source of nicotinamide governs its metabolic fate in cultured cells, mice, and humans.
130. Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors
131. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
132. Retraction Note: NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages
133. Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice
134. In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma
135. C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D
136. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
137. C-Raf Inhibits MAPK Activation and Transformation by B-RafV600E
138. RAS in cellular transformation and senescence
139. mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation.
140. A tandem activity-based sensing and labeling strategy reveals antioxidant response element regulation of labile iron pools.
141. Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis.
142. Dynamic ROS control by TIGAR regulates the initiation and progression of pancreatic cancer
143. Dynamic ROS control by TIGAR regulates the initiation and progression of pancreatic cancer
144. Oxidation state-specific fluorescent copper sensors reveal oncogene-driven redox changes that regulate labile copper(II) pools.
145. Ferroptosis in health and disease.
146. ASCT2 is a major contributor to serine uptake in cancer cells.
147. Glutathione synthesis in the mouse liver supports lipid abundance through NRF2 repression.
148. Drug screening in human physiologic medium identifies uric acid as an inhibitor of rigosertib efficacy.
149. Mitochondrial respiratory function is preserved under cysteine starvation via glutathione catabolism in NSCLC.
150. MAPK-mediated PHGDH induction is essential for melanoma formation and represents an actionable vulnerability.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.